CF-Vanillin 是一种具有口服活性的降血脂/保肝剂,对 PPAR-α 具有良好的结合亲和力,可通过激活 Nrf2/HO-1 信号通路发挥抗氧化和抗炎作用,降低甘油三酯和总胆固醇水平并减轻肝损伤,因此可用于高脂血症和肝损伤等疾病的研究。
产品编号: MS-Z20136 CAS No.: 1323378-95-5 分子式: C18H17ClO5 分子量: 348.78
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

CF-Vanillin 是一种具有口服活性的降血脂/保肝剂,对 PPAR-α 具有良好的结合亲和力,可通过激活 Nrf2/HO-1 信号通路发挥抗氧化和抗炎作用,降低甘油三酯和总胆固醇水平并减轻肝损伤,因此可用于高脂血症和肝损伤等疾病的研究。

生物实验数据

生物活性 CF-Vanillin is an orally active lipid-lowering/hepatoprotective agent with good binding affinity for PPAR-α that exerts antioxidant and anti-inflammatory effects by activating the Nrf2/HO-1 signaling pathway, reduces triglyceride and total cholesterol levels, and alleviates liver injury, and can therefore be used for research on diseases such as hyperlipidemia and liver injury.
IC50 & Target

PPARα

 

IL-6

 

HO-1

 

体内研究
(In Vivo)

CF-Vanillin (0.1335-0.534 mmol/kg; 7 days) 在高脂血症小鼠中表现出剂量依赖性的显著降血脂活性。
CF-Vanillin (1.65 mmol/kg; i.g.; 30 days) 可通过上调 Nrf2/HO-1 信号通路以缓解氧化应激与炎症,显著减轻健康小鼠的肝损伤。

Animal Model: Triton WR 1339-induced hyperlipidemic mice
Dosage: 0.534 mmol/kg; 0.267 mmol/kg; 0.1335 mmol/kg
Administration: once daily; 7 days
Result: Reduced serum TG by 28.82% and serum TC by 37.23% at 0.534 mmol/kg.
Reduced serum TG by 24.32% and serum TC by 29.51% at 0.267 mmol/kg.
Reduced serum TG by 21.83% and serum TC by 19.07% at 0.1335 mmol/kg.
Animal Model: Healthy mice
Dosage: 1.65 mmol/kg
Administration: i.g.; once daily; 30 days
Result: Showed no significant difference in body weight relative to control or CF groups.
Significantly reduced liver weight and liver coefficient relative to the CF group.
Significantly reduced serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels relative to the CF group.
Reduced serum alkaline phosphatase (AKP) levels but not significantly.
Significantly increased serum superoxide dismutase (SOD) levels relative to the CF group, significantly increased serum glutathione (GSH) levels relative to the CF group, and significantly reduced serum malondialdehyde (MDA) levels relative to the CF group.
Significantly reduced liver tissue tumor necrosis factor-alpha (TNF-α) protein expression relative to the CF group.
Reduced interleukin-6 (IL-6) protein expression but not significantly.
Showed no inflammatory cell infiltration and only mild hepatocyte swelling, compared to marked hepatocyte swelling, necrosis, nuclear degeneration/dissolution, and inflammatory cell infiltration in the CF group.
Significantly upregulated liver tissue Nrf2 protein expression relative to the CF group, and significantly upregulated HO-1 protein expression relative to the CF group.

化学信息

分子量 348.78
分子式 C18H17ClO5
CAS No. 1323378-95-5

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础